Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway

Oncology Reports

Volumn 29, Issue 2, 2013, Pages 507-514

  Chen, Hongman ^a,b   Wang, Yingmei ^a   Xue, Fengxia ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN FIFTH CENTRAL HOSPITAL   (China)

Author keywords

Apoptosis; Endometrial cancer; Proliferation; Wnt catenin pathway; Wnt10a; Wnt10b

Indexed keywords

APC PROTEIN; BETA CATENIN; MYC PROTEIN; WNT10A PROTEIN; WNT10B PROTEIN;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER TISSUE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ADENOMATOUS POLYPOSIS COLI PROTEIN; APOPTOSIS; BETA CATENIN; CARCINOMA; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL PROLIFERATION; CHI-SQUARE DISTRIBUTION; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENE SILENCING; HUMANS; HYPERPLASIA; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, SMALL INTERFERING; STATISTICS, NONPARAMETRIC; TRANSFECTION; UP-REGULATION; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84872821599     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2126     Document Type: Article

References (32)

1. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
2. Yang D and Han L: Year 1969-2003 study on evolution of endometrial cancer. FuDan Univ J Med Sci 32: 479-483, 2005.
3. Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15: 10-17, 1983. (Pubitemid 13194678)
4. Fleming GF: Systemic chemotherapy for uterine carcinoma: metastatic and adjuvant. J Clin Oncol 25: 2983-2990, 2007. (Pubitemid 47123163)
5. Nusse R: Wnt signaling in disease and in development. Cell Res 15: 28-32, 2005. (Pubitemid 41653961)
6. Katoh M: WNT and FGF gene clusters (Review): Int J Oncol 21: 1269-1273, 2002.
7. Wend P, Wend K, Krum SA and Miranda-Carboni GA: The role of WNT10B in physiology and disease. Acta Physiol (Oxf) 204: 34-51, 2012.
8. Modder UI, Oursler MJ, Khosla S and Monroe DG: Wnt10b activates the Wnt, notch and NFκB pathways in U2OS osteosarcoma cells. J Cell Biochem 112: 1392-1402, 2011.
9. White BD, Chien AJ and Dawson DW: Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers. Gastroenterology 142: 219-232, 2012.
10. Robinson DR, Zylstra CR and Williams BO: Wnt signaling and prostate cancer. Curr Drug Targets 9: 571-580, 2008.
11. Mukheriee N, Bhattacharya N, Alam N, et al: Subtype-specific alteration of the Wnt signaling pathway in breast cancer: clinical and prognostic significance. Cancer Sci 103: 210-220, 2012.
12. Gatcliffe TA, Monk BJ, Planutis K and Holcombe RF: Wnt signaling in ovarian tumorigenesis. Int J Gynecol Cancer 18: 954-962, 2008.
13. Carmon KS and Loose DS: Development of bioassay for detection of Wnt-binding affinities for individual frizzled receptors. Anal Biochem 401: 288-294, 2010.
14. Kirikoshi H, Sekihara H and Katoh M: WNT10A and WNT6, clustered in human chromosome 2q35 region with head-to-tail manner, are strongly co-expressed in SW480 cells. Biochem Biophy Res Commun 283: 798-805, 2001. (Pubitemid 32924650)
15. Benhaj K, Akcali KC and Oztuk M: Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol Rep 15: 701-707, 2006.
16. Saegusa M, Hashimura M, Yoshida T and Okayasu I: Beta-catenin mutations and aberrant nuclear expression during endometrial tumorigenesis. Br J Cancer 84: 209-217, 2001. (Pubitemid 32113448)
17. Wang Y, Yang D, Cogdell D, Hu L, Xue F, Broaddus R and Zhang W: Genomic characterization of gene copy-number aberrations in endometrial carcinoma cell lines derived from endometrioid-type endometrial adenocarcinoma. Technol Cancer Res Treat 9: 179-189, 2010.
18. Dellinger TH, Planutis K, Tewari KS and Holcombe RF: Role of canonical Wnt signaling in endometrial carcinogenesis. Expert Rev Anticancer Ther 12: 51-62, 2012.
19. Kirikoshi H, Inoue S, Sekihara H and Katoh M: Expression of WNT10A in human cancer. Int J Oncol 19: 997-1001, 2001.
20. Brennan KR and Brown AM: Wnt proteins in mammary development and cancer. J Mammary Gland Biol Neoplasia 9: 119-131, 2004. (Pubitemid 39177498)
21. Barbolina M V, Burkhalter RJ and Stack MS: Diverse mechanisms for activation of Wnt signaling in the ovarian tumour microenviroment. Biochem J 437: 1-12, 2011.
22. Kirikoshi H, Sekihara H and Katoh M: Up-regulation of WNT10A by tumor necrosis factor alpha and Helicobacter pylori in gastric cancer. Int J Oncol 19: 533-536, 2001.
23. Milovanovic T, Planutis K, Nquyen A, Marsh JL, Lin F, Hope C and Holcombe RF: Expression of Wnt genes and frizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma. Int J Oncol 25: 1337-1342, 2004.
24. Kharaishvili G, Simkova D, Makharoblidze E, et al: Wnt signaling in prostate development and carcinogenesis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 155: 11-18, 2011.
25. Nishida M: The Ishikawa cells from birth to the present. Hum Cell 15: 104-117, 2002.
26. Lustig B and Behrens J: The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 129: 199-221, 2003. (Pubitemid 36713796)
27. Fernandez-Cobo M, Zammarchi F, Mandeli J, Holland JF and Pogo BG: Expression of Wnt5A and Wnt10b in non-immortalized breast cancer cells. Oncol Rep 17: 903-907, 2007.
28. Scholten AN, Creutzberg CL, van den Broek LJ, Noordijk EM and Smit VT: Nuclear beta-catenin is a molecular feature of type 1 endometrial carcinoma. J Pathol 201: 460-465, 2003. (Pubitemid 37408267)
29. Polakis P: Wnt signaling and cancer. Genes Dev 14: 1837-1851, 2000. (Pubitemid 30639518)
30. Wang Y, van der Zee, Fodde R and Blok LJ: Wnt/B-catenin and sex hormone signaling in endometrial homeostasis and cancer. Oncotarget 1: 674-684, 2010.
31. Kirikoshi H and Katoh M: Expression and regulation of WNT10B in human cancer: up-regulation of WNT10B in MCF-7 cells by beta-estradiol and down-regulation of WNT10B in NT2 cells by retinoic acid. Int J Mol Med 10: 507-511, 2002.
32. Lu Lu KH, Wu W, Dave B, Slomovitz BM, Burke TW, Munsell MF, Broaddus RR and Walker CL: Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Clin Cancer Res 14: 2543-2550, 2008.